* Cosmos Health Inc COSM.OQ reported a quarterly adjusted
loss
of 45 cents per share for the quarter ended September 30. The
lone analyst forecast for the quarter was for a loss of 11 cents
per share.
* Revenue was $12.41 million; analysts expected $14.00
million.
* Cosmos Health Inc's reported EPS for the quarter was a
loss
of 45 cents.
* The company reported a quarterly loss of $8.38 million.
* Cosmos Health Inc shares had fallen by 28.1% this
quarter and
lost 55.3% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"
Wall Street's median 12-month price target for Cosmos Health Inc
is $4.00
This summary was machine generated from LSEG data November 18 at
10:01 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -0.11 -0.45 Missed
Jun. 30 2024 -0.14 -0.15 Missed
Mar. 31 2024 -0.14 -0.11 Beat
Dec. 31 2023 -0.20 -1.73 Missed